Targeting both GD2 and B7-H3 using bispecific antibody improves tumor selectivity for GD2-positive tumors is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5T32CA009206-18
U.W. RADIOLOGICAL SCIENCES TRAINING PROGRAM
National Institutes of Health
Grant: 5R01HL153721-02
Exosome educated monocytes for acute radiation syndrome
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 1R35CA197078-01
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
National Institutes of Health
Grant: 5P01CA250972-02
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
NCI NIH HHS
Grant: R35 CA197078
NCI NIH HHS
Grant: P30 CA014520
NCI NIH HHS
Grant: T32 CA009206
NHLBI NIH HHS
Grant: R01 HL153721
NCI NIH HHS
Grant: P01 CA250972
Fields of Study
Keywords
Sustainable Development Goals